Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Purchased by Stephens Inc. AR

Stephens Inc. AR lifted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 25.2% in the fourth quarter, HoldingsChannel reports. The firm owned 5,627 shares of the company’s stock after purchasing an additional 1,134 shares during the period. Stephens Inc. AR’s holdings in Acadia Healthcare were worth $223,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. State Street Corp boosted its position in shares of Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after purchasing an additional 95,613 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after purchasing an additional 454,044 shares during the period. SG Americas Securities LLC boosted its position in Acadia Healthcare by 713.3% during the 4th quarter. SG Americas Securities LLC now owns 110,866 shares of the company’s stock worth $4,396,000 after acquiring an additional 97,235 shares during the period. LMR Partners LLP acquired a new stake in Acadia Healthcare during the 3rd quarter worth about $1,616,000. Finally, Sivik Global Healthcare LLC boosted its position in Acadia Healthcare by 43.7% during the 3rd quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock worth $7,292,000 after acquiring an additional 34,997 shares during the period.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $41.06 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market cap of $3.81 billion, a P/E ratio of 13.46, a P/E/G ratio of 1.75 and a beta of 1.30. The business’s fifty day moving average is $42.09 and its two-hundred day moving average is $53.90. Acadia Healthcare Company, Inc. has a 52 week low of $36.50 and a 52 week high of $87.77.

Analyst Upgrades and Downgrades

ACHC has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. KeyCorp upgraded Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective for the company in a research report on Tuesday, January 7th. TD Cowen reduced their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. Barclays reduced their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a report on Tuesday, December 10th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.